Understanding COPD and cardiovascular disease in Greece

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather comprehensive data on patients suffering from Chronic Obstructive Pulmonary Disease (COPD) and cardiovascular diseases (CVD) in Greece. It will document the demographic and clinical characteristics of this population, track COPD- and CVD-related adverse events over a two-year period, and assess their quality of life and healthcare resource utilization. The study is coordinated by the Hellenic Thoracic Society and involves multiple centers across Greece.

Why it matters

Who can join: the full rules

Inclusion criteria

Patients should cumulatively meet the following three (3) criteria to be enrolled in the study:

1. To have been diagnosed with chronic obstructive pulmonary disease and at least one cardiovascular comorbidity (heart failure, atherosclerotic cardiovascular disease, atrial Fibrillation, severe valvular disease)
2. Adults aged \>35 years at the time of inclusion in the study,
3. With signed informed consent for their participation in the study. Exclusion criteria Patients with the below limitations are not eligible to participate in the study

Patients:

1. Without at least one cardiovascular comorbidity,
2. With history of lung cancer
3. With any other active malignancy and undergoing treatment (chemotherapy/radiotherapy/immunotherapy)
4. With any thoracic or abdominal surgery planned during study follow-up period
5. With participation in any COPD-related interventional study at study entry or during study duration.
6. Without signed informed consent for their participation in the study.

Where it's running

• Department of Respiratory Medicine, Medical School, Democritus University of Thrace, University General Hospital
  Alexandroupoli, Greece Recruiting
• 5th Pulmonary Department, "Sotiria" Chest Diseases Hospital, Athens, Greece
  Athens, Greece Recruiting

Study contacts

• Principal investigator: Georgios Hillas — 5th Pulmonary Department, "Sotiria" Chest Diseases Hospital, Athens, Greece
• Study coordinator: Stylianos Loukides
• Email: loukstel@med.uoa.gr
• Phone: +306944380549

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Health for Hungary: Long-term blood and health data collection to study aging and disease onset

  This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.

  Recruiting at 21 sites Center for Molecular Fingerprinting Research Nonprofit LLC · Balatonfüred and 32 other locations · NCT07743021

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• Tailored digital support to cut sedentary time in long-term cardiac rehab

  In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

  Recruiting University of Lisbon · Lisbon, Lisbon District · NCT07910812

• IOS-based platform to screen, diagnose, and manage COPD and asthma

  This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.

  Recruiting Beijing Chao Yang Hospital · Beijing, Beijing Municipality · NCT07910409

• Targeted NMES to improve breathing and leg/extra muscle strength in COPD

  This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.

  Recruiting Universitas Padjadjaran · Bandung, West Java · NCT07910006

• AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

  This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

  Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.